Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study

Aman, Mohammad Iqbal, Noormal, Bashir, Diaz, Virginia, Espinoza, Marisa, Pasquale, Julia, Leroy, Charlotte, Roelens, Kristien, Vandenberghe, Griet, Agossou, M Christian Urlyss, Keke, Sourou Goufodji
et al (show 157 more authors) (2020) Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study. The Lancet Global Health, 8 (5). E661-E671.

Access the full-text of this item by clicking on the Open Access link.


Background Maternal infections are an important cause of maternal mortality and severe maternal morbidity. We report the main findings of the WHO Global Maternal Sepsis Study, which aimed to assess the frequency of maternal infections in health facilities, according to maternal characteristics and outcomes, and coverage of core practices for early identification and management. Methods We did a facility-based, prospective, 1-week inception cohort study in 713 health facilities providing obstetric, midwifery, or abortion care, or where women could be admitted because of complications of pregnancy, childbirth, post-partum, or post-abortion, in 52 low-income and middle-income countries (LMICs) and high-income countries (HICs). We obtained data from hospital records for all pregnant or recently pregnant women hospitalised with suspected or confirmed infection. We calculated ratios of infection and infection-related severe maternal outcomes (ie, death or near-miss) per 1000 livebirths and the proportion of intrahospital fatalities across country income groups, as well as the distribution of demographic, obstetric, clinical characteristics and outcomes, and coverage of a set of core practices for identification and management across infection severity groups. Findings Between Nov 28, 2017, and Dec 4, 2017, of 2965 women assessed for eligibility, 2850 pregnant or recently pregnant women with suspected or confirmed infection were included. 70·4 (95% CI 67·7–73·1) hospitalised women per 1000 livebirths had a maternal infection, and 10·9 (9·8–12·0) women per 1000 livebirths presented with infection-related (underlying or contributing cause) severe maternal outcomes. Highest ratios were observed in LMICs and the lowest in HICs. The proportion of intrahospital fatalities was 6·8% among women with severe maternal outcomes, with the highest proportion in low-income countries. Infection-related maternal deaths represented more than half of the intrahospital deaths. Around two-thirds (63·9%, n=1821) of the women had a complete set of vital signs recorded, or received antimicrobials the day of suspicion or diagnosis of the infection (70·2%, n=1875), without marked differences across severity groups. Interpretation The frequency of maternal infections requiring management in health facilities is high. Our results suggest that contribution of direct (obstetric) and indirect (non-obstetric) infections to overall maternal deaths is greater than previously thought. Improvement of early identification is urgently needed, as well as prompt management of women with infections in health facilities by implementing effective evidence-based practices.

Item Type: Article
Uncontrolled Keywords: WHO Global Maternal Sepsis Study (GLOSS) Research Group, Humans, Pregnancy Complications, Infectious, Incidence, Cohort Studies, Pregnancy, Adult, Health Facilities, Female, Global Health
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 30 Jun 2021 09:54
Last Modified: 15 Mar 2024 16:19
DOI: 10.1016/S2214-109X(20)30109-1
Open Access URL:
Related URLs: